1. Home
  2. TK vs ABCL Comparison

TK vs ABCL Comparison

Compare TK & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teekay Corporation

TK

Teekay Corporation

HOLD

Current Price

$12.21

Market Cap

1.1B

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.44

Market Cap

910.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TK
ABCL
Founded
1973
2012
Country
Bermuda
Canada
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
910.0M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
TK
ABCL
Price
$12.21
$3.44
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$7.75
AVG Volume (30 Days)
656.7K
3.1M
Earning Date
01-01-0001
05-26-2026
Dividend Yield
16.38%
N/A
EPS Growth
N/A
10.91
EPS
N/A
N/A
Revenue
N/A
$75,128,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$16.59
P/E Ratio
$13.43
N/A
Revenue Growth
N/A
160.56
52 Week Low
$5.65
$1.89
52 Week High
$13.76
$6.52

Technical Indicators

Market Signals
Indicator
TK
ABCL
Relative Strength Index (RSI) 59.71 48.73
Support Level $9.11 $3.37
Resistance Level N/A $3.57
Average True Range (ATR) 0.52 0.22
MACD -0.05 0.06
Stochastic Oscillator 38.96 54.02

Price Performance

Historical Comparison
TK
ABCL

About TK Teekay Corporation

Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: